AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 3083705
Drug: Oral neomycin
RxNorm normalized name: neomycin Oral Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral neomycin and erythromycin
Trial: 31023274
Drug: Circadian Reinforcement
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Circadian Reinforcement Therapy (CRT) combined with electronic self-monitoring (Monsenso Daybuilder System)
Trial: 20642710
Drug: Statins (atorvastatin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Statins (atorvastatin 10 mg, atorvastatin 80 mg, pravastatin 40 mg/day)
Trial: 16131799
Drug: ZK 200775
RxNorm normalized name: ZK-93423
DrugBank: ZK-93423 (DB17063)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ZK 200775 (525 mg in 48 h)
Trial: 16131799
Drug: ZK 200775
RxNorm normalized name: ZK-93423
DrugBank: ZK-93423 (DB17063)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ZK 200775 (105 mg over 6 h)
Trial: 10628893
Drug: INN 00835
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: INN 00835 (0.2 mg/kg, subcutaneously, once daily for 5 days)
Trial: 10628893
Drug: Placebo (subcutaneously,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (subcutaneously, once daily for 5 days)
Trial: 384241
Drug: Vitamin C
RxNorm normalized name: Vitamin C
DrugBank: Sodium ascorbate (DB14482)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin C (10 g per day)
Trial: 26338890
Drug: Cocoa beverage
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cocoa beverage (960 mg total polyphenols; 480 mg flavanols)
Trial: 26338890
Drug: Flavanol-free placebo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flavanol-free placebo (110 mg total polyphenols; <0.1 mg flavanols)
Trial: 23670706
Drug: Lithium treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lithium treatment (n=28)
Trial: 23670706
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no lithium treatment, n=32)
Trial: 18976879
Drug: Self-weighing at
RxNorm normalized name: rose bengal AT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Self-weighing at least weekly
Trial: 15364747
Drug: IV amiodarone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IV amiodarone (0.73 mg/min for 48 hours) followed by oral amiodarone (400 mg q12h for 3 days)
Trial: 10743904
Drug: Commonly prescribed
RxNorm normalized name: Common carp
DrugBank: Common carp (DB10614)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Commonly prescribed analgesic medications
Trial: 10743904
Drug: Participant-rated measures
RxNorm normalized name: MEASLES VIRUS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Participant-rated measures of drug liking and mood
Trial: 8245113
Drug: Home-based burn
RxNorm normalized name: Burn Jel Plus
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Home-based burn treatment modality
Trial: 29615049
Drug: SB010 (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SB010 (10 mg bid for 28 days)
Trial: 24197517
Drug: Low-power laser
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-power laser at low dose (30 mW, 10 J/cm², 9 s per point, 810 nm)
Trial: 24197517
Drug: Low-power laser
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-power laser at high dose (100 mW, 90 J/cm², 11 s per point, 810 nm)
Trial: 24197517
Drug: Low-power laser
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-power laser at low dose + Gluma Desensitizer
Trial: 24197517
Drug: Low-power laser
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-power laser at high dose + Gluma Desensitizer
Trial: 21568831
Drug: Handling strategies
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Handling strategies + specific strength exercises + weekly physiotherapist training
Trial: 19309586
Drug: Intensive therapy
RxNorm normalized name: Cortaid Intensive Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intensive therapy group (methylprednisolone, cyclophosphamide, Etanercept)
Trial: 26786575
Drug: Intensive therapy
RxNorm normalized name: Cortaid Intensive Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intensive therapy group
Trial: 19309586
Drug: Normal therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normal therapy group
Trial: 9526601
Drug: 3 ml
RxNorm normalized name: WATER,INHL 3 ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 ml normal saline (N/S group)
Trial: 9526601
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg tenoxicam (T group)
Trial: 1286128
Drug: TTPG 180
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TTPG 180 mg
Trial: 1286128
Drug: TTPG 540
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TTPG 540 mg
Trial: 1286128
Drug: TTPG 1080
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TTPG 1080 mg
Trial: 1286128
Drug: TCA 180
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TCA 180 mg
Trial: 1286128
Drug: TCA 540
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TCA 540 mg
Trial: 1286128
Drug: TCA 1080
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TCA 1080 mg
Trial: 1286128
Drug: tiopronin 180
FDA approved: no
EMA approved: no
PMDA approved: no
Description: tiopronin 180 mg
Trial: 1286128
Drug: tiopronin 540
FDA approved: no
EMA approved: no
PMDA approved: no
Description: tiopronin 540 mg
Trial: 1286128
Drug: tiopronin 1080
FDA approved: no
EMA approved: no
PMDA approved: no
Description: tiopronin 1080 mg
Trial: 16912706
Drug: Control (current
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (current immunosuppressive treatment)
Trial: 10951338
Drug: Gemcitabine 1250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gemcitabine 1250 mg/m² and vinorelbine 25 mg/m² administered on Days 1 and 8 every 3 weeks for up to 9 courses
Trial: 7941897
Drug: Adjuvant intramuscular
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjuvant intramuscular immunoglobulin against tick‐borne encephalitis
Trial: 7941897
Drug: Nonspecific treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nonspecific treatment alone
Trial: 2895840
Drug: 400 mg
RxNorm normalized name: mesna 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 mg twice a day
Trial: 2895840
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg four times a day
Trial: 2895840
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg once a day
Trial: 2895840
Drug: After stopping
FDA approved: no
EMA approved: no
PMDA approved: no
Description: After stopping treatment
Trial: 28666335
Drug: Ginger 160
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ginger 160 mg/day
Trial: 7725886
Drug: Ropivacaine 2.5
RxNorm normalized name: fentanyl-ropivacaine 2.5 mcg/mL-0.1%-0.9% injectable solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ropivacaine 2.5 mg/ml
Trial: 9773132
Drug: Bupivacaine 2.5
RxNorm normalized name: Sure-Amp BUPivacaine 2.5 MG/ML Injectable Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bupivacaine 2.5 mg/ml
Trial: 8582131
Drug: Metformin (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin (2 x 850 mg day-1 for 2 days and 850 mg 1 h before evaluation)
Trial: 645073
Drug: Dipyrone (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dipyrone (20 mg per kg body weight i.v.)
Trial: 23053764
Drug: Ultra-short-course chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ultra-short-course chemotherapy (2SHRZ/XHRZ) for an average duration of 4.5 months
Trial: 23053764
Drug: Standard chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard chemotherapy for an average duration of 9 months
Trial: 23053764
Drug: Ultra-short-course chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ultra-short-course chemotherapy
Trial: 19489966
Drug: Metvix cream
RxNorm normalized name: Metvixia
DrugBank: Methyl aminolevulinate (DB00992)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Metvix cream
Trial: 16728551
Drug: Testosterone therapy
RxNorm normalized name: Testosterone
DrugBank: (1,2,6,7-3H)Testosterone (DB14093)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Testosterone therapy (200 mg i.m. every 2 weeks for 3 months)
Trial: 15327915
Drug: Regular cola
RxNorm normalized name: cola extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Regular cola (710 ml, 24 oz)
Trial: 15327915
Drug: Fat-free raspberry
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fat-free raspberry cookies (87 g, 3 oz)
Trial: 10938022
Drug: Fish oil
RxNorm normalized name: Fish oil
DrugBank: Fish oil (DB13961)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fish oil supplementation (3.0 g eicosapentaenoic acid/docosahexaenoic acid per day)
Trial: 3313686
Drug: Diltiazem (0.3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diltiazem (0.3 mg/kg intravenously)
Trial: 30038151
Drug: Oral valproic
RxNorm normalized name: Valproic Acid
DrugBank: Valproic acid (DB00313)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral valproic acid (VPA) 500 mg once a day for 3 months
Trial: 30038151
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group continued on glaucoma therapy (n = 33 eyes)
Trial: 26945271
Drug: Tolterodine (Detrol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tolterodine (Detrol LA) extended release daily for 12 weeks
Trial: 26945271
Drug: Intravaginal estradiol
RxNorm normalized name: Estradiol
DrugBank: Estradiol acetate (DB13952)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravaginal estradiol cream (Estrace) nightly for 6 weeks then twice per week for 12 weeks
Trial: 26945271
Drug: Combined therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined therapy (intravaginal estradiol + tolterodine) at 24 weeks
Trial: 26945271
Drug: Combined therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined therapy (intravaginal estradiol + tolterodine) at 52 weeks
Trial: 22918855
Drug: Test formulation
RxNorm normalized name: mumps skin test antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Test formulation of zolmitriptan 5 mg orodispersible tablet
Trial: 22918855
Drug: Reference formulation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reference formulation of zolmitriptan 5 mg orodispersible tablet
Trial: 18487744
Drug: Computer-based scoring
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Computer-based scoring tool (tablet PC with standalone scoring application for TISS, SAPS2, and Apache 2)
Trial: 15787917
Drug: Midazolam (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Midazolam (0.5 mg x kg(‐1) orally, 30 min before surgery)
Trial: 12853806
Drug: Electrical stimulation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Electrical stimulation (ES) for 15 minutes twice daily
Trial: 12853806
Drug: Biofeedback (BFB)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Biofeedback (BFB) for 15 minutes twice daily
Trial: 10391261
Drug: TMR surgery
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TMR surgery and medication
Trial: 1323943
Drug: Acyclovir, 800
RxNorm normalized name: Acyclovir, 800 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acyclovir, 800 mg orally five times per day for 7 days
Trial: 29957401
Drug: Growth hormone
RxNorm normalized name: Growth hormone
DrugBank: Somatotropin (DB00052)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Growth hormone (GH) adjuvant therapy to the long down regulation protocol
Trial: 23026181
Drug: Nasal steroid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nasal steroid (mometasone furoate nasal spray)
Trial: 23026181
Drug: Antihistamine (fexofenadine)
RxNorm normalized name: Ahist Antihistamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antihistamine (fexofenadine)
Trial: 15292338
Drug: Estrogen (Ovcon
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Estrogen (Ovcon 35, 35 microg ethinyl estradiol, and 0.4 mg norethindrone)
Trial: 15292338
Drug: Recombinant human
RxNorm normalized name: Recombinant human TNF
DrugBank: Etanercept (DB00005)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Recombinant human IGF-I (30 microg/kg sc twice a day)
Trial: 15292338
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of Estrogen and rhIGF-I
Trial: 15292338
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of rhIGF-I and E
Trial: 11853331
Drug: Hyperimmune bovine
RxNorm normalized name: Cryptosporidium hyperimmune bovine colostrum IgG
DrugBank: Cryptosporidium immune globulin (DB17785)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hyperimmune bovine colostrum (HBC) 100 ml three times a day for 3 days
Trial: 11853331
Drug: HBC and
RxNorm normalized name: Aminosyn-HBC 7 %, Sulfite-Free
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HBC and BC with pivmecillinam 50 mg kg(‐1) d(‐1) for 5 days
Trial: 7868973
Drug: LDL-apheresis without
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LDL-apheresis without statin therapy
Trial: 7868973
Drug: LDL-apheresis with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LDL-apheresis with statin therapy (lovastatin or pravastatin)
Trial: 3364227
Drug: Group Behavioral
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group Behavioral Marital Therapy (BMT)
Trial: 3364227
Drug: Interactional Marital
RxNorm normalized name: barbital
DrugBank: Barbital (DB01483)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interactional Marital Therapy
Trial: 24815298
Drug: Probiotic (Symprove)
RxNorm normalized name: Rezyst Probiotic
DrugBank: Bifidobacterium longum (DB19248)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Probiotic (Symprove) 1 mL/kg/day for 12 weeks
Trial: 15721727
Drug: Cisatracurium (CIS)
RxNorm normalized name: Cisatracurium
DrugBank: Cisatracurium (DB00565)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cisatracurium (CIS) 0.10 mg/kg
Trial: 15721727
Drug: Rocuronium (ROC)
DrugBank: Rocuronium (DB00728)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Rocuronium (ROC) 0.60 mg/kg
Trial: 12824971
Drug: 3 days
RxNorm normalized name: Transderm Scop 1mg/3 days Transdermal System
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 days of ampicillin-sulbactam (3 g intravenously every 6 hours)
Trial: 12824971
Drug: 7 days
RxNorm normalized name: ZINGIBER OFFICINALE (GINGER) ROOT OIL 0.006 mg in 30 mg TOPICAL LIQUID [JAYSUING 7 Days Nail Fungus Treatment]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 7 days of ampicillin-sulbactam (3 g intravenously every 6 hours)
Trial: 1495748
Drug: IL-2 (9
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IL-2 (9 x 10(6) IU/m2, subcutaneously, twice daily for 3 days before surgery)
Trial: 29688200
Drug: Standard comprehensive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard comprehensive conservative treatment
Trial: 16187469
Drug: Oral nonsteroidal
RxNorm normalized name: isopropyl alcohol
DrugBank: Isopropyl alcohol (DB02325)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral nonsteroidal antiinflammatory drugs (NSAIDs)
Trial: 16187469
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy (diclofenac-paracetamol)
Trial: 16187469
Drug: Diclofenac-paracetamol combination
RxNorm normalized name: diclofenac, combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diclofenac-paracetamol combination
Trial: 16187469
Drug: All combinations
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All combinations (NSAIDs, paracetamol, diclofenac-paracetamol)
Trial: 12519847
Drug: GnRH agonist
RxNorm normalized name: GnRH
DrugBank: Gonadorelin (DB00644)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: GnRH agonist long protocol (group A; n = 45)
Trial: 12519847
Drug: GnRH antagonist
RxNorm normalized name: GnRH
DrugBank: Gonadorelin (DB00644)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: GnRH antagonist protocol commencing recombinant FSH on cycle day 2 (group B; n = 48)
Trial: 12519847
Drug: GnRH antagonist
RxNorm normalized name: GnRH
DrugBank: Gonadorelin (DB00644)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: GnRH antagonist protocol commencing recombinant FSH on cycle day 5 (group C; n = 49)
Trial: 1353803
Drug: Active nicotine
RxNorm normalized name: Nicotine
DrugBank: Nicotine (DB00184)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Active nicotine nasal spray (0.5 mg per shot)
Trial: 12225705
Drug: Active nicotine
RxNorm normalized name: Nicotine
DrugBank: Nicotine (DB00184)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Active nicotine nasal spray
Trial: 1353803
Drug: Active nicotine
RxNorm normalized name: Nicotine
DrugBank: Nicotine (DB00184)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Active nicotine nasal spray and Placebo nasal spray
Trial: 6501724
Drug: Nifedipine (34
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nifedipine (34 +/- 22 mg)
Trial: 6501724
Drug: Hydralazine (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydralazine (10 +/- 5 mg)
Trial: 31182176
Drug: Psychotropic medication
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Psychotropic medication prescribed on discharge (including neuroleptics, antidepressants, anxiolytics)
Trial: 29575951
Drug: Concurrent training
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Concurrent training protocol (3 times weekly, 60 minutes per session for 6 months)
Trial: 26595966
Drug: Combined therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined therapy with PLIESF and therapeutic physical exercises
Trial: 24213914
Drug: Structured Treatment
RxNorm normalized name: Lipid,structured (From Sunflower Oil)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Structured Treatment Interruptions (STIs) consisting of five STIs of 1, 1, 2, 2, and 3 months, respectively, separated by four periods of 3-month therapy
Trial: 24213914
Drug: Standard continuous
RxNorm normalized name: Uniphyllin Continus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard continuous treatment
Trial: 18065829
Drug: Oral nutritional
RxNorm normalized name: Ocean Blue Nutritionals Omega-3 1450 Oral Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral nutritional supplementation combined with a single bout of resistance exercise (PO + EX)
Trial: 18065829
Drug: Oral nutritional
RxNorm normalized name: Ocean Blue Nutritionals Omega-3 1450 Oral Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral nutritional supplementation alone (PO)
Trial: 16758243
Drug: Reboxetine (8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reboxetine (8 mg/day; n=20)
Trial: 16758243
Drug: Mirtazapine (45
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mirtazapine (45 mg/day; n=20)
Trial: 12766690
Drug: Cognitive-processing therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive-processing therapy
Trial: 12766690
Drug: Delayed-treatment waiting-list
RxNorm normalized name: salicylic acid
DrugBank: Salicylic acid (DB00936)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Delayed-treatment waiting-list condition
Trial: 9050084
Drug: Pimozide (8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pimozide (8 mg)
Trial: 9050084
Drug: d-Amphetamine (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: d-Amphetamine (10 and 20 mg)
Trial: 9050084
Drug: Pimozide (8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pimozide (8 mg) + d-Amphetamine (10 and 20 mg)
Trial: 1315651
Drug: Lithium carbonate
RxNorm normalized name: Lithium Carbonate
DrugBank: Lithium carbonate (DB14509)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lithium carbonate (800 mg)
Trial: 6421918
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg of sodium cromoglycate (SCG)
Trial: 24591191
Drug: Sublingual administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sublingual administration of D. farinae drops for 48 weeks
Trial: 22112683
Drug: Prior warfarin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prior warfarin only
Trial: 22112683
Drug: Prior ASA
RxNorm normalized name: Aspirin
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Prior ASA and warfarin
Trial: 22112683
Drug: No prior
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No prior therapy
Trial: 17975496
Drug: Temsirolimus 250
RxNorm normalized name: Temsirolimus
DrugBank: Temsirolimus (DB06287)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Temsirolimus 250 mg
Trial: 17975496
Drug: Overall (both
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Overall (both doses)
Trial: 15777522
Drug: Moxifloxacin (1000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moxifloxacin (1000 mg total dose, single blind, one day oral provocation test)
Trial: 2695999
Drug: Personalized prescription
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Personalized prescription
Trial: 2695999
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (standard prescription)